PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells

Cancer Letters

Volumn 291, Issue 2, 2010, Pages 177-186

  Yu, Jian ^a,c   Lan, Jianping ^a,b,c   Wang, Chong ^a   Wu, Quan ^c   Zhu, Yuanyuan ^a   Lai, Xiaoyu ^a   Sun, Jie ^a   Jin, Changjiang ^c   Huang, He ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c Hefei National Laboratory for Physical Sciences at Nanoscale   (China)

Author keywords

ALT associated PML bodies; Alternative lengthening of telomeres; PML3; TRF1

Indexed keywords

BINDING PROTEIN; ISOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN 3; SMALL INTERFERING RNA; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG;

ALTERNATIVE LENGTHENING OF TELOMERE ASSOCIATED PROMYELOCYTIC LEUKEMIA BODY; ARTICLE; CELL DIVISION; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA BODY; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TELOMERE;

CELL CYCLE; DNA, COMPLEMENTARY; FLUORESCENT ANTIBODY TECHNIQUE; GLUTATHIONE TRANSFERASE; HUMANS; KINETICS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICROSATELLITE REPEATS; NUCLEAR PROTEINS; PALATINE TONSIL; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TELOMERIC REPEAT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 77950021419     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.10.009     Document Type: Article

References (35)

1. de Lange T. Protection of mammalian telomeres. Oncogene 21 (2002) 532-540
2. Blackburn E.H. Structure and function of telomeres. Nature 350 (1991) 569-673
3. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41 (1973) 181-190
4. Allsopp R.C., Chang E., Kashefi-Aazam M., Rogaev E.I., Piatyszek M.A., Shay J.W., and Harley C.B. Telomere shortening is associated with cell division in vitro and in vivo. Exp. Cell Res. 220 (1995) 194-200
5. Shay J.W., and Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33 (1997) 787-791
6. Bryan T.M., Englezou A., Gupta J., Bacchetti S., and Reddel R.R. Telomeres elongation in immortal human cells without detectable telomerase activity. EMBO J. 14 (1995) 4240-4248
7. Muntoni A., and Reddel R.R. The first molecular details of ALT in human tumor cells. Hum. Mol. Genet. 14 (2005) R191-R196
8. Yeager T.R., Neumann A.A., Englezou A., Huschtscha L.I., Noble J.R., and Reddel R.R. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59 (1999) 4175-4179
9. Wu G., Jiang X., Lee W.-H., and Chen P.-L. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res. 63 (2003) 2589-2595
10. Johnson F.B., Marciniak R.A., McVey M., Stewart S.A., Hahn W.C., and Guarente L. The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J. 20 (2001) 905-913
11. Stavropoulos D.J., Bradshaw P.S., Li X., Pasic I., Truong K., Ikura M., Ungrin M., and Meyn M.S. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum. Mol. Genet. 11 (2002) 3135-3144
12. Yankiwski V., Marciniak R.A., Guarente L., and Neff N.F. Nuclear structure in normal and Bloom syndrome cells. Proc. Natl. Acad. Sci. USA 97 (2000) 5214-5219
13. Wu G., Lee W.-H., and Chen P.-L. NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. J. Biol. Chem. 275 (2000) 30618-30622
14. Naka K., Ikeda K., and Motoyama N. Recruitment of NBS1 into PML oncogenic domains via interaction with SP100 protein. Biochem. Biophys. Res. Commun. 299 (2002) 863-871
15. Jiang W.-Q., Zhong Z.-H., Henson J.D., and Reddel R.R. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene 26 (2007) 4635-4647
16. Fan Q., Zhang F., Barrett B., Ren K., and Andreassen P.R. A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res. 37 (2009) 1740-1754
17. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19 (2005) 2100-2110
18. Potts P.R., and Yu H. The SMC5/6 complex maintains telomere length in ALT cancer cells through sumoylation of telomere-binding proteins. Nat. Struct. Mol. Biol. 14 (2007) 581-590
19. Melnick A., and Licht J.D. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93 (1999) 3167-3215
20. Bernardi R., and Pandolfi P.P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8 (2007) 1006-1016
21. Jensen K., Shiels C., and Freemont P.S. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20 (2001) 7223-7233
22. Fogal V., Gostissa M., Sandy P., Zacchi P., Sternsdorf T., Jensen K., Pandolfi P.P., Will H., Schneider C., and Del Sal G. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19 (2000) 6185-6195
23. Wu Q., Hu H., Lan J., Emenari C., Wang Z., Chang K.S., Huang H., and Yao X. PML3 orchestrates the nuclear dynamics and function of TIP60. J. Biol. Chem. 284 (2009) 8747-8759
24. Liu D., Zhang N., Du J., Cai X., Zhu M., Jin C., Dou Z., Feng C., Yang Y., Liu L., Takeyasu K., Xie W., and Yao X. Interaction of Skp1 with CENP-E at the midbody is essential for cytokinesis. Biochem. Biophys. Res. Commun. 345 (2006) 394-402
25. Glued and regulates its ubiquitination. Biochem. Biophys. Res. Commun. 359 (2007) 34-39
26. Yu J., Lan J., Zhu Y., Li X., Lai X., Xue Y., Jin C., and Huang H. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara. Biochem. Biophys. Res. Commun. 367 (2008) 805-812
27. Li X., Lan J., Zhu Y., Yu J., Dou Z., and Huang H. Expression, purification, and characterization of Tara, a novel telomere repeat-binding factor 1 (TRF1)-binding protein. Protein Expres. Purif. 55 (2007) 84-92
28. Xu Z.-X., Zou W.-X., Lin P., and Chang K.-S. A role for PML3 in centrosome duplication and genome stability. Mol. Cell 17 (2005) 721-732
29. Yao X., Abrieu A., Zheng Y., Sullivan K.F., and Cleveland D.W. CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint. Nat. Cell Biol. 2 (2000) 484-491
30. Fu C., Ahmed K., Ding H., Ding X., Lan J., Yang Z., Miao Y., Zhu Y., Shi Y., Zhu J., Huang H., and Yao X. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene 24 (2005) 5401-5413
31. Grobelny J.V., Godwin A.K., and Broccoli D. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. J. Cell Sci. 113 (2000) 4577-4585
32. Dunham M.A., Neumann A.A., Fasching C.L., and Reddel R.R. Telomere maintenance by recombination in human cells. Nat. Genet. 26 (2000) 447-450
33. Perrem K., Colgin L.M., Neumann A.A., Yeager T.R., and Reddel R.R. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell Biol. 21 (2001) 3862-3875
34. Jiang W.-Q., Zhong Z.-H., Henson J.D., Neumann A.A., Chang A.C., and Reddel R.R. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol. Cell Biol. 25 (2005) 2708-2721
35. Zhong Z.-H., Jiang W.-Q., Cesare A.J., Neumann A.A., Wadhwa R., and Reddel R.R. Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J. Biol. Chem. 282 (2007) 29314-29322